Vimentin (D21H3) Rabbit Monoclonal Antib…

The University of Nebraska Medical Center (UNMC), a state agency operating under the Board of Regents of the University of Nebraska, awarded a purchase order (PO #4800180254) to Cell Signaling Technology Inc., headquartered in Boston, Massachusetts, for the procurement of research-grade antibodies. The contract, valued at $2,688.00, covers seven units of Vimentin (D21H3) Rabbit Monoclonal Antibody (material number 5741S) at a unit price of $384.00 per item. The award was issued on February 17, 2026, with a completion date of February 24, 2026, establishing a seven-day performance period. Delivery is specified to UNMC Shipping and Receiving in Omaha, Nebraska, under Free on Board (FOB) Destination terms with freight prepaid.

Payment terms for this purchase order are Net 30, with the State of Nebraska accepting Treasury warrants as payment method. Cell Signaling Technology Inc. is required to acknowledge the purchase order within ten days of issuance and to reference the PO number on all packages, invoices, and related documentation. The transaction is governed by the Standard Terms of Purchase established by the University of Nebraska unless superseded by an existing agreement between the vendor and the Board of Regents. This procurement supports the research and diagnostic capabilities of the University of Nebraska Medical Center in Omaha.